130 related articles for article (PubMed ID: 12649667)
21. Acral lentiginous melanoma: an immunohistochemical study of 20 cases.
Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH
Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000
[TBL] [Abstract][Full Text] [Related]
22. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
[TBL] [Abstract][Full Text] [Related]
23. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
Gleason BC; Nascimento AF
Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
[TBL] [Abstract][Full Text] [Related]
24. Melanoma metastatic to the breast: utility of fine needle aspiration and immunohistochemistry.
Filie AC; Simsir A; Fetsch P; Abati A
Acta Cytol; 2002; 46(1):13-8. PubMed ID: 11843553
[TBL] [Abstract][Full Text] [Related]
25. Is MAGE-1 expression in metastatic malignant melanomas really helpful?
Gajjar NA; Cochran AJ; Binder SW
Am J Surg Pathol; 2004 Jul; 28(7):883-8. PubMed ID: 15223957
[TBL] [Abstract][Full Text] [Related]
26. [Cutaneous regressing/regressed malignant melanoma: a clinicopathologic analysis of 8 cases].
Shen XX; Kong YY; Dai B; Cai X; Wang LW; Kong JC
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):675-8. PubMed ID: 24433730
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanoma.
Reinke S; Königer P; Herberth G; Audring H; Wang H; Ma J; Guo Y; Sterry W; Trefzer U
Am J Dermatopathol; 2005 Oct; 27(5):401-6. PubMed ID: 16148409
[TBL] [Abstract][Full Text] [Related]
28. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
Orchard GE
Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
[TBL] [Abstract][Full Text] [Related]
29. Primary melanoma of the lung: a clinicopathologic and immunohistochemical study of eight cases.
Wilson RW; Moran CA
Am J Surg Pathol; 1997 Oct; 21(10):1196-202. PubMed ID: 9331292
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous melanoma with myxoid features: twelve cases with differential diagnosis.
Hitchcock MG; McCalmont TH; White WL
Am J Surg Pathol; 1999 Dec; 23(12):1506-13. PubMed ID: 10584704
[TBL] [Abstract][Full Text] [Related]
31. Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy.
Trefzer U; Hofmann M; Reinke S; Guo YJ; Audring H; Spagnoli G; Sterry W
Melanoma Res; 2006 Apr; 16(2):137-45. PubMed ID: 16567969
[TBL] [Abstract][Full Text] [Related]
32. Expression of Sox-9 in metastatic melanoma--a potential diagnostic pitfall.
Rao P; Fuller GN; Prieto VG
Am J Dermatopathol; 2010 May; 32(3):262-266. PubMed ID: 20098296
[TBL] [Abstract][Full Text] [Related]
33. Small cell type malignant melanoma which developed in a 16-year-old female with a congenital dermal nevus and metastasized 12 years after excision.
Miura K; Harada H; Tsutsui Y
Pathol Int; 1999 Mar; 49(3):247-52. PubMed ID: 10338082
[TBL] [Abstract][Full Text] [Related]
34. S100, HMB-45, and Melan-A negative primary melanoma.
Shinohara MM; Deubner H; Argenyi ZB
Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
[TBL] [Abstract][Full Text] [Related]
35. Malignant melanoma with paradoxical maturation.
Ruhoy SM; Prieto VG; Eliason SL; Grichnik JM; Burchette JL; Shea CR
Am J Surg Pathol; 2000 Dec; 24(12):1600-14. PubMed ID: 11117780
[TBL] [Abstract][Full Text] [Related]
36. Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patients.
Hoon DS; Kuo CT; Wascher RA; Fournier P; Wang HJ; O'Day SJ
J Invest Dermatol; 2001 Aug; 117(2):375-8. PubMed ID: 11511319
[TBL] [Abstract][Full Text] [Related]
37. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
[TBL] [Abstract][Full Text] [Related]
38. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation.
Hoang MP; Prieto VG; Burchette JL; Shea CR
J Cutan Pathol; 2001 Sep; 28(8):400-6. PubMed ID: 11493377
[TBL] [Abstract][Full Text] [Related]
39. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update.
Ordóñez NG
Hum Pathol; 2014 Feb; 45(2):191-205. PubMed ID: 23648379
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical distinction of epithelioid histiocytic proliferations from epithelioid melanocytic nevi.
Busam KJ; Granter SR; Iversen K; Jungbluth AA
Am J Dermatopathol; 2000 Jun; 22(3):237-41. PubMed ID: 10871066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
